Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02970981
Title Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine



Ipilimumab + Nivolumab

Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.